Hitoshi Ohmori
Impact in
- Immunology top 1%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research
Papers in
-
- Advanced Glycation End Products research 17
- Immunology 64
- T-cell and B-cell Immunology 36
- Immune Cell Function and Interaction 32
- Immunotherapy and Immune Responses 13
- Co-authors
- Hiroki KuniyasuToshiyuki TakaiTomonori SasahiraKiyomu FujiiMasaki HikidaTakamitsu SasakiMasao OnoYi Luo
- Journals
- International Journal of Molecular Sciences (22 papers)Pathobiology (16 papers)Immunology Letters (9 papers)Cancer Science (9 papers)Oncotarget (7 papers)
- Partner nations
- JapanChinaUnited States
In The Last Decade
Hitoshi Ohmori
199 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Immunology 1.8k
- Clinical Biochemistry 557
- Cancer Research 604
- Immunology and Allergy 201
- Biochemistry 221
Countries citing papers authored by Hitoshi Ohmori
This map shows the geographic impact of Hitoshi Ohmori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Ohmori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Ohmori more than expected).
Fields of papers citing papers by Hitoshi Ohmori
This network shows the impact of papers produced by Hitoshi Ohmori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Ohmori. The network helps show where Hitoshi Ohmori may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hitoshi Ohmori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 15 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 11 | |
| 7 | 2016 | 44 | |
| 8 | 2012 | 27 | |
| 9 | 2012 | 6 | |
| 10 | 2006 | 22 | |
| 11 | 2005 | 38 | |
| 12 | 2002 | 17 | |
| 13 | 2001 | 3 | |
| 14 | 1999 | 2 | |
| 15 | 1998 | 63 | |
| 16 | Highly efficient DNA transfection of hematopoietic cell lines by an improved DEAE-dextran method: A synergistic enhancement by hypertonic treatment and dimethyl sulfoxide | 1990 | 5 |
| 17 | 1990 | 37 | |
| 18 | 1987 | 1 | |
| 19 | 1982 | 77 | |
| 20 | 1981 | 2 |
About Hitoshi Ohmori
Hitoshi Ohmori is a scholar working on Clinical Biochemistry, Immunology, Cancer Research, Biochemistry and Molecular Biology, having authored 207 papers that have together received 5.1k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (36 papers), Immune Cell Function and Interaction (32 papers), Monoclonal and Polyclonal Antibodies Research (25 papers), Cancer, Hypoxia, and Metabolism (19 papers), Advanced Glycation End Products research (17 papers), RNA Interference and Gene Delivery (14 papers), Cancer, Lipids, and Metabolism (14 papers) and Immunotherapy and Immune Responses (13 papers). The work is most often cited by research in Immunology (1.8k citations), Clinical Biochemistry (557 citations), Cancer Research (604 citations), Immunology and Allergy (201 citations) and Biochemistry (221 citations). Hitoshi Ohmori has collaborated with scholars based in Japan, China and United States. Frequent co-authors include Hiroki Kuniyasu, Toshiyuki Takai, Tomonori Sasahira, Kiyomu Fujii, Masaki Hikida, Masaki Hikida, Takamitsu Sasaki, Masao Ono, Yi Luo and Naoki Kanayama. Their work appears in journals such as International Journal of Molecular Sciences, Pathobiology, Immunology Letters, Cancer Science and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.